trimetrexate has been researched along with Dermatitis, Exfoliative in 1 studies
Trimetrexate: A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.
Dermatitis, Exfoliative: The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weiss, RB | 1 |
| James, WD | 1 |
| Major, WB | 1 |
| Porter, MB | 1 |
| Allegra, CJ | 1 |
| Curt, GA | 1 |
1 other study available for trimetrexate and Dermatitis, Exfoliative
| Article | Year |
|---|---|
Skin reactions induced by trimetrexate, an analog of methotrexate.
Topics: Cellulitis; Dermatitis, Exfoliative; Humans; Quinazolines; Skin Diseases; Trimetrexate | 1986 |